Ulf Bremberg
Technik-/Wissenschafts-/F&E-Leiter bei Beactica Therapeutics AB
Ursprung des Netzwerks ersten Grades von Ulf Bremberg
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden.
10
| Holding Company | Medical Distributors | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ulf Bremberg
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| GENOVIS AB | Medical Specialties | Chairman Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| AstraZeneca AS | Corporate Officer/Principal | ||
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
AgResearch Ltd.
 AgResearch Ltd. Miscellaneous Commercial ServicesCommercial Services AgResearch Ltd. engages in research and development activities in the pastoral sector. It offers NaturOTM analgesia system, CARLA Saliva Test, WormFEC and MicroManual products. Its services include bioinformatics, development engineering, farms and deoxyribonucleic acid testing laboratory. The company was founded in 1992 and is headquartered in Hamilton, New Zealand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Stockholm | College/University | Doctorate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Lund | College/University | Doctorate Degree | |
| Henley Management College | College/University | Masters Business Admin | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Graduate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| International Space University | College/University | Graduate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
CarpoNovum AB
 CarpoNovum AB Medical SpecialtiesHealth Technology CarpoNovum AB develops and provides surgical instruments. Its products include CARP RapAn, CARP FixAid, CARP FixAid no cath, CARP LapAid, CARP DMHC, CARP pressure measure device and CARP test devices. The company was founded by Henrik Tobias Thorlacius and Grönberg Anders Georg in 2006 and is headquartered in Halmstad, Sweden. | Medical Specialties | Director/Board Member | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Chief Executive Officer | |
Sahlgrenska Universitetssjukhuset
 Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Hospital/Nursing Management | Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| Pfizer NV/SA | Corporate Officer/Principal | ||
| BIOVICA INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Mesothelioma Applied Research Foundation, Inc. | Director/Board Member | ||
| RYVU THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| XINTELA AB | Biotechnology | Director/Board Member | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Chief Executive Officer | |
Monocl AB
 Monocl AB Internet Software/ServicesTechnology Services Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden. | Internet Software/Services | Director/Board Member | |
| TME PHARMA N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer | |
| Healthcom GmbH | Corporate Officer/Principal | ||
| ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
UK Research & Innovation
 UK Research & Innovation BiotechnologyHealth Technology UK Research & Innovation is a partnership organization that works with universities, research organizations, businesses, charities, and government to create an environment that fosters research and innovation. The private company is based in London, UK. The organization aims to maximize the contribution of each component part, working both individually and collectively. UKRI collaborates with many partners to benefit everyone through knowledge, talent, and ideas. | Biotechnology | Director/Board Member | |
Amarna Therapeutics BV
 Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Biotechnology | Director/Board Member | |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
| GHW Consulting AB | Director/Board Member | ||
Tekiu Ltd.
 Tekiu Ltd. Internet Software/ServicesTechnology Services Tekiu Ltd. operates internet blogs that focus on trance and progressive house music. The British company was founded by Ted Ingemar Jakob Fjällman. | Internet Software/Services | Founder | |
| Cavis Technologies AB | Director/Board Member | ||
Buzzard Pharmaceuticals AB
 Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Chief Executive Officer | |
| Beactica Therapeutics | Director/Board Member Chairman | ||
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Alder Therapeutics AB
 Alder Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Alder Therapeutics AB is a cell therapy platform company that aims to develop and manufacture functional cell therapy products based on simple and robust processes. The company is based in Solna, Sweden. The Swedish company's unique platform allows for the manufacturing of better cells at a lower cost, making pluripotent cell therapy treatment available to more patients. The CEO of the company is Kristian Tryggvason. | Miscellaneous Commercial Services | Director/Board Member | |
| Termino C 2915 AB | Chairman | ||
| AstraZeneca BioVentureHub AB | Chief Executive Officer |
Statistik
International
| Schweden | 32 |
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 4 |
| Norwegen | 3 |
| Deutschland | 3 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 8 |
| Commercial Services | 8 |
| Health Services | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 83 |
| Corporate Officer/Principal | 31 |
| Chairman | 23 |
| Chief Executive Officer | 21 |
| Independent Dir/Board Member | 13 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Ulf Bremberg
- Unternehmensverbindungen